Navigation Links
MedImmune Announces Seven Key Promotions and New Hires
Date:11/5/2007

and finally as a patent attorney over a course of six years. Mr. Klein-Evans holds a juris doctorate degree from Georgetown University Law Center; a master of science degree in biological sciences from Stanford University; and a bachelor of arts degree in biochemistry from Columbia University.

Mr. Tim Pearson was previously vice president, finance, and treasurer, and has been named chief financial officer, responsible for overseeing the company's financial and accounting obligations. Since joining MedImmune in 1998, Mr. Pearson has raised more than $1.6 billion in debt throughout the course of his tenure, and served as corporate secretary from 2000-2004. Previously, Mr. Pearson worked at Integrated Health Services, Inc., most recently as assistant treasurer; at CIGNA Insurance as treasury manager; and at First National Bank of Maryland as a commercial lending officer. He holds a master of science degree in finance from Loyola College; a bachelor of science degree in accounting from the University of Maryland; and a bachelor of science degree in business administration from the University of Delaware.

Mr. Paul Williams was promoted to vice president, sales operations, and is now responsible for overseeing market research and marketing operations as well as for managing core sales operations competencies. Prior to joining MedImmune, Mr. Williams was a senior director at Centocor, Inc., guiding trade sales, customer supply chain and channel strategy. Mr. Williams holds a bachelor of science degree in finance from Virginia Polytechnic Institute and State University in Blacksburg, Virginia.

About MedImmune

MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. With approximately 3,000 employees worldwide and headquarters in Maryland, MedImmune is dedicated to advancing science and medicine to help people live better lives and is wholly owned by AstraZeneca plc (LSE: AZN.L,
'/>"/>

SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
2. MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters
3. MedImmune Recognized by Local Volunteer Organization for Its Employees Exceptional Commitment to Community Service within Montgomery County
4. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
5. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Colo. , Jan. 23, 2015  Array BioPharma Inc. ... has reached a definitive agreement with Novartis Pharma AG ... inhibitor currently in Phase 3 development.  This agreement is conditional ... GlaxoSmithKline PLC (GSK) on April 22, 2014, which are expected ...
(Date:1/22/2015)... , Jan. 22, 2015  Transwestern | RBJ today announces ... of office space for Shire a leading biopharmaceutical company, at ... Transwestern | RBJ,s Robert Richards , president, and ... lease for the entire five-floor building at 95 Hayden Ave. ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The laboratory ... that has witnessed a number of technological advancements due ... regulatory requirements, growing need to integrate healthcare systems, and ... ease challenges in system integration. Key players in the ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 zFlo Motion ... pleased to announce an exciting product from a new partner. ... analysis solutions over the past 15 years, with offerings in ... recently, their 3D IMU system (inertial measurement unit), iSen, is ...
Breaking Biology Technology:Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 2Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 3Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 4Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 5Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 6Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 7Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 43D Motion Capture Just Got Easy 2
... InterMune, Inc.,(Nasdaq: ITMN ) today announced that ... present at the BMO Capital Markets 2008 Focus,on Healthcare ... 10:00 a.m. EDT., To access a live audio ... log on to the investor relations page of InterMune,s,corporate ...
... Bioheart, Inc.,(Nasdaq: BHRT ) a company ... monitor, diagnose and treat heart failure and,cardiovascular diseases, ... June 30, 2008., Recent Clinical Highlights:, ... the results of a preclinical,study involving the injection ...
... ... patients into screening completed in second LymphoStat-B(R), Phase 3 trial in systemic lupus erythematosus; completion of randomization ... expected in August 2008 -, - Initial data from Phase 2 ... third quarter 2008 ...
Cached Biology Technology:Bioheart, Inc. Announces Financial Results for Second Quarter 2008 2Bioheart, Inc. Announces Financial Results for Second Quarter 2008 3Bioheart, Inc. Announces Financial Results for Second Quarter 2008 4Bioheart, Inc. Announces Financial Results for Second Quarter 2008 5Bioheart, Inc. Announces Financial Results for Second Quarter 2008 6Bioheart, Inc. Announces Financial Results for Second Quarter 2008 7Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 2Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 3Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 4Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 5Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 6Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 7Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 8Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 9
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... addition of the "The Global Watermarking and ... http://photos.prnewswire.com/prnh/20130307/600769 ... digital media watermarking and fingerprinting markets. Watermarking aims ...
(Date:12/19/2014)... Markets ( http://www.researchandmarkets.com/research/8kmfcn/iphone_5s ) has announced the ... Apple/AuthenTec TMDR92 & Sapphire - Technology Report" report ... Following the acquisition of AuthenTec in ... the iPhone 5S. It is currently the only device ...
(Date:12/19/2014)... MOUNTAIN VIEW, Calif. , Dec. 18, 2014  23andMe, Inc., ... a study that pinpoints fine-scale differences in genetic ancestry of ... Since immigrants first arrived more than four hundred ... served as a meeting place for peoples from different continents. ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
... human world record for the most densely populated space and ... equivalent, the most species rich area on earth. The team,s ... reveal the record is contested between South America,s tropical rainforests ... of species in one space and the questions it raises ...
... he knows what was ailing Tiny Tim, the iconic character ... descriptions of both the symptoms and living conditions of 18th ... a combination of rickets and tuberculosis (TB). His findings ... of Pediatrics and Adolescent Medicine . Dr. ...
... a way to create temporary holes in the membranes of ... be published in JoVE, the Journal of Visualized Experiments ... for this method when we wanted to be able to ... on cells," said paper-author Dr. Delphine Dean. She said ...
Cached Biology News:European grasslands challenge rainforests as the most species-rich spaces on Earth 2Researchers print live cells with a standard inkjet printer 2
Comp Dim: chamber diam. depth 20 2.8 mm chamber maximum volume 720 μL...
... vitro diagnostic assays, all EIA/RIA plates are ... binding, high optical clarity and low background ... of the Certified Surface Chemistry Programme, which ... QA release specifications. Linkage: This CLS number ...
... clarification reagent; Ideal for clarifying many ... proteins, nucleic acids, & proteoglycans; Contains ... improves downstream processing; Utilizes a reagent ... supplied as a suspension in saline; ...
... The lyophilization stabilizer is designed to ... and for long-term storage. There ... ingredients. It is a convenient ... 7.2, and is superior to other ...
Biology Products: